Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate

    NEXT STORY
    Bone Therapeutics announces results of Annual General Meeting
    PREV STORY
    Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    $36 Billion Point of Care Testing Market – Global Forecast to 2024 By Diagnostics, Mode, End Users, Regions and Companies

    Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The "Point of Care Testing Market, Global ...

    author_avatar
    NASDAQ Market News

    Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech’s Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run

    author_avatar
    NASDAQ Market News